XML 90 R70.htm IDEA: XBRL DOCUMENT v3.6.0.2
Acquisitions (Schedule Of Pro Forma Consolidated Results) (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Paladin Labs Inc.    
Business Acquisition, Equity Interests Issued or Issuable [Line Items]    
Revenue   $ 2,423,683
Net loss attributable to Endo International plc   $ (727,961)
Basic net income (loss) per share (in dollars per share)   $ (4.96)
Diluted net income (loss) per share (in dollars per share)   $ (4.64)
Auxilium Pharmaceuticals, Inc.    
Business Acquisition, Equity Interests Issued or Issuable [Line Items]    
Revenue $ 3,292,293  
Net loss attributable to Endo International plc $ (1,513,625)  
Basic net income (loss) per share (in dollars per share) $ (7.68)  
Diluted net income (loss) per share (in dollars per share) $ (7.68)  
Par Pharmaceutical Holdings, Inc.    
Business Acquisition, Equity Interests Issued or Issuable [Line Items]    
Revenue $ 4,268,110  
Net loss attributable to Endo International plc $ (1,594,130)  
Basic net income (loss) per share (in dollars per share) $ (8.09)  
Diluted net income (loss) per share (in dollars per share) $ (8.09)